Intercept Pharmaceuticals reported $618K in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amarin AMRN:US $ 32.16M 3.83M
Amgen AMGN:US $ 1637M 147M
AstraZeneca AZN:LN 2193M 273M
Biogen BIIB:US $ 511.8M 52.1M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Bristol Myers Squibb BMY:US $ 2451M 52M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Novartis NOVN:VX SF 3754M 79M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M